ABSTRACT
Background The rapid global spread of the COVID-19 pandemic affected different regions, communities, and individuals in vastly different ways that interdisciplinary social scientists are well-positioned to document and investigate. This paper describes an innovative mixed-methods dataset generated by a research study that was designed to chronicle and preserve evidence of the pandemic’s divergent effects: the Pandemic Journaling Project (PJP). The dataset was generated by leveraging digital technology to invite ordinary people around the world to document the impact of the COVID-19 pandemic on their everyday lives over a two-year period (May 2020-May 2022) using text, images, and audio.
Methods and Findings PJP’s weekly, online, bilingual (English/Spanish) journaling platform was open to anyone with access to a smartphone or computer, including teens aged 15–17 with permission of a parent or guardian. Participants first completed a baseline quantitative survey, after which they were invited to create two journal entries in response to suggested narrative prompts. In each subsequent week, participants received weekly invitations to contribute via their choice of email or SMS (text message). Each invitation included a link to that week’s journaling prompts and accompanying survey questions.
Participants could join the project at any point between May 2020 and May 2022. PJP employed a cohort design. Regardless of when they joined, all received the narrative prompts and accompanying survey questions in the same order. Participants could stop participating at any point, and they could later restart if they wished. The project welcomed any interested participant and sought to capture as broad a range of perspectives as possible, while also taking measures to include voices that might not otherwise be preserved in the historical record.
The project launched in May 2020. In the two years it operated as a weekly journaling platform, PJP generated nearly 27,000 individual journal entries from over 1,800 people in 55 countries around the world. Data from PJP’s first phase (PJP-1) are now accessible at the Qualitative Data Repository (QDR) at Syracuse University.
Conclusions The first phase of the Pandemic Journaling Project has produced an innovative multimedia dataset that can support studies of how the COVID-19 pandemic has affected a wide range of communities across a wide range of outcomes including mental health, reproductive health, vaccine hesitancy, and trust in health professionals, among others. The dataset is available to researchers who follow established data protection protocols and procedures. These data protection measures will be in place for 25 years, through 2049, after which all PJP-1 data will become a fully accessible public archive via QDR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of Connecticut IRB, IRB Protocol H20-0065. Participants provided written (electronic) consent for participation. The participant information sheet is available as part of the dataset at https://doi.org/10.5064/F6PXS9ZK/4IARO6
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.